Cns Pharmaceuticals, Inc.

This study tests an experimental drug called berubicin in adults whose glioblastoma (a fast-growing brain cancer) has come back after standard treatment. About 252 participants will receive either berubicin or a standard chemotherapy drug (lomustine) to see which helps them live …